{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:30:23Z","timestamp":1790692223391,"version":"4.1.0"},"reference-count":142,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["20fk0210033h0003"],"award-info":[{"award-number":["20fk0210033h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20fk0310107s0504"],"award-info":[{"award-number":["JP20fk0310107s0504"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20fk0310109h0004"],"award-info":[{"award-number":["JP20fk0310109h0004"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["21k08006"],"award-info":[{"award-number":["21k08006"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Chronic hepatitis B virus (HBV) infection is a global health problem that can lead to liver dysfunction, including liver cirrhosis and hepatocellular carcinoma (HCC). Current antiviral therapies can control viral replication in patients with chronic HBV infection; however, there is a risk of HCC development. HBV-related proteins may be produced in hepatocytes regardless of antiviral therapies and influence intracellular metabolism and signaling pathways, resulting in liver carcinogenesis. To understand the mechanisms of liver carcinogenesis, the effect of HBV infection in human hepatocytes should be analyzed. HBV infects human hepatocytes through transfer to the sodium taurocholate co-transporting polypeptide (NTCP). Although the NTCP is expressed on the hepatocyte surface in several animals, including mice, HBV infection is limited to human primates. Due to this species-specific liver tropism, suitable animal models for analyzing HBV replication and developing antivirals have been lacking since the discovery of the virus. Recently, a humanized mouse model carrying human hepatocytes in the liver was developed based on several immunodeficient mice; this is useful for analyzing the HBV life cycle, antiviral effects of existing\/novel antivirals, and intracellular signaling pathways under HBV infection. Herein, the usefulness of human hepatocyte chimeric mouse models in the analysis of HBV-associated hepatocarcinogenesis is discussed.<\/jats:p>","DOI":"10.3390\/v13101920","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T23:08:31Z","timestamp":1632784111000},"page":"1920","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Are Humanized Mouse Models Useful for Basic Research of Hepatocarcinogenesis through Chronic Hepatitis B Virus Infection?"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7591-8287","authenticated-orcid":false,"given":"Masataka","family":"Tsuge","sequence":"first","affiliation":[{"name":"Natural Science Center for Basic Research and Development, Department of Biomedical Science, Research and Development Division, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan"},{"name":"Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan"},{"name":"Research Center for Hepatology and Gastroenterology, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,24]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2021, September 14). Hepatitis B, Fact Sheets. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1080\/21645515.2020.1852869","article-title":"Long-term immune protection against HBV: Associated factors and determinants","volume":"17","author":"Mastrodomenico","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.20760","article-title":"Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine","volume":"42","author":"Papatheodoridis","year":"2005","journal-title":"Hepatology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1053\/jhep.2003.50148","article-title":"Long-term suppression of hepatitis B e antigen-negative chronic hepatitis B by 24-month interferon therapy","volume":"37","author":"Lampertico","year":"2003","journal-title":"Hepatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/hep.21723","article-title":"Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis","volume":"46","author":"Buster","year":"2007","journal-title":"Hepatology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0168-8278(99)80123-8","article-title":"Histological changes in liver biopsies after one year of lamivudine treatment in patients with chronic hepatitis B infection","volume":"30","author":"Suzuki","year":"1999","journal-title":"J. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1053\/j.gastro.2006.09.020","article-title":"Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years","volume":"131","author":"Hadziyannis","year":"2006","journal-title":"Gastroenterology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jhep.2009.12.036","article-title":"Long-term use of entecavir in nucleoside-naive Japanese patients with chronic hepatitis B infection","volume":"52","author":"Yokosuka","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","article-title":"Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: A 5-year open-label follow-up study","volume":"381","author":"Marcellin","year":"2013","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/S0168-8278(02)00431-2","article-title":"Management of chronic hepatitis B","volume":"38","author":"Conjeevaram","year":"2003","journal-title":"J. Hepatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1872-034X.2009.00633.x","article-title":"Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan","volume":"40","author":"Kumada","year":"2010","journal-title":"Hepatol. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/hep.21189","article-title":"Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy","volume":"43","author":"Lee","year":"2006","journal-title":"Hepatology"},{"key":"ref_13","unstructured":"(2021, July 21). Compounds in Development for Chronic Hepatitis B. Available online: https:\/\/www.hepb.org\/treatment-and-management\/drug-watch\/."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/hep.26125","article-title":"A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant","volume":"57","author":"Sureau","year":"2013","journal-title":"Hepatology"},{"key":"ref_15","first-page":"122","article-title":"Role of glycosaminoglycans for binding and infection of hepatitis B virus","volume":"10","author":"Leistner","year":"2008","journal-title":"Cell. Microbiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/hep.21896","article-title":"Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans","volume":"46","author":"Schulze","year":"2007","journal-title":"Hepatology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3748\/wjg.v13.i1.22","article-title":"Viral and cellular determinants involved in hepadnaviral entry","volume":"13","author":"Glebe","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e00049","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"eLife"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1073\/pnas.0401771101","article-title":"Genomic analysis of the host response to hepatitis B virus infection","volume":"101","author":"Wieland","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/hep.26211","article-title":"Hepatitis B virus hepatotropism is mediated by specific receptor recognition in the liver and not restricted to susceptible hosts","volume":"58","author":"Schieck","year":"2013","journal-title":"Hepatology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/hep.27694","article-title":"Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na(+) -taurocholate cotransporting polypeptide knockout mice","volume":"62","author":"Slijepcevic","year":"2015","journal-title":"Hepatology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1073\/pnas.88.4.1217","article-title":"Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation","volume":"88","author":"Ponder","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1073\/pnas.89.1.89","article-title":"Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes","volume":"89","author":"Kay","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"8437","DOI":"10.1073\/pnas.87.21.8437","article-title":"Temporary amelioration of hyperlipidemia in low density lipoprotein receptor-deficient rabbits transplanted with genetically modified hepatocytes","volume":"87","author":"Wilson","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1126\/science.8108734","article-title":"Replacement of diseased mouse liver by hepatic cell transplantation","volume":"263","author":"Rhim","year":"1994","journal-title":"Science"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0092-8674(90)90010-C","article-title":"Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator","volume":"62","author":"Heckel","year":"1990","journal-title":"Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.1073\/pnas.92.11.4942","article-title":"Complete reconstitution of mouse liver with xenogeneic hepatocytes","volume":"92","author":"Rhim","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1053\/jhep.2001.23314","article-title":"Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus","volume":"33","author":"Dandri","year":"2001","journal-title":"Hepatology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/90968","article-title":"Hepatitis C virus replication in mice with chimeric human livers","volume":"7","author":"Mercer","year":"2001","journal-title":"Nat. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0002-9440(10)63352-4","article-title":"Near completely humanized liver in mice shows human-type metabolic responses to drugs","volume":"165","author":"Tateno","year":"2004","journal-title":"Am. J. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/hep.20892","article-title":"Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus","volume":"42","author":"Tsuge","year":"2005","journal-title":"Hepatology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.febslet.2007.04.021","article-title":"Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis C virus and its susceptibility to interferon","volume":"581","author":"Hiraga","year":"2007","journal-title":"FEBS Lett."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.bbrc.2011.01.042","article-title":"The reconstituted \u2018humanized liver\u2019 in TK-NOG mice is mature and functional","volume":"405","author":"Hasegawa","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bbrc.2013.10.040","article-title":"A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections","volume":"441","author":"Kosaka","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.3748\/wjg.v12.i9.1439","article-title":"Effects of retrorsine on mouse hepatocyte proliferation after liver injury","volume":"12","author":"Zhou","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1172\/JCI40094","article-title":"Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment","volume":"120","author":"Bissig","year":"2010","journal-title":"J. Clin. Invest."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ng0895-453","article-title":"Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I","volume":"10","author":"Grompe","year":"1995","journal-title":"Nat. Genet."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nbt1326","article-title":"Robust expansion of human hepatocytes in Fah\u2212\/\u2212\/Rag2\u2212\/\u2212\/Il2rg\u2212\/\u2212 mice","volume":"25","author":"Azuma","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Tateno, C., Kawase, Y., Tobita, Y., Hamamura, S., Ohshita, H., Yokomichi, H., Sanada, H., Kakuni, M., Shiota, A., and Kojima, Y. (2015). Generation of Novel Chimeric Mice with Humanized Livers by Using Hemizygous cDNA-uPA\/SCID Mice. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0142145"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1099\/jgv.0.000726","article-title":"Usefulness of humanized cDNA-uPA\/SCID mice for the study of hepatitis B virus and hepatitis C virus virology","volume":"98","author":"Uchida","year":"2017","journal-title":"J. Gen. Virol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1099\/vir.0.019224-0","article-title":"HBx protein is indispensable for development of viraemia in human hepatocyte chimeric mice","volume":"91","author":"Tsuge","year":"2010","journal-title":"J. Gen. Virol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Liu, Y., Maya, S., and Ploss, A. (2021). Animal Models of Hepatitis B Virus Infection-Success, Challenges, and Future Directions. Viruses, 13.","DOI":"10.3390\/v13050777"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/978-1-4939-6700-1_23","article-title":"Studying HBV Infection and Therapy in Immune-Deficient NOD-Rag1\u2212\/\u2212IL2RgammaC-null (NRG) Fumarylacetoacetate Hydrolase (Fah) Knockout Mice Transplanted with Human Hepatocytes","volume":"1540","author":"Li","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/hep.29891","article-title":"Acute hepatitis B virus infection in humanized chimeric mice has multiphasic viral kinetics","volume":"68","author":"Ishida","year":"2018","journal-title":"Hepatology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1172\/JCI42338","article-title":"New horizons for studying human hepatotropic infections","volume":"120","author":"Rice","year":"2010","journal-title":"J. Clin. Invest."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.jhep.2016.02.012","article-title":"Experimental in vitro and in vivo models for the study of human hepatitis B virus infection","volume":"64","author":"Allweiss","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e0049220","DOI":"10.1128\/JVI.00492-20","article-title":"Understanding hepatitis B virus dynamics and the antiviral effect of interferon-alpha treatment in humanized chimeric mice","volume":"95","author":"Reinharz","year":"2021","journal-title":"J. Virol"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1128\/AAC.00239-06","article-title":"Emergence of a novel lamivudine-resistant hepatitis B virus variant with a substitution outside the YMDD motif","volume":"50","author":"Yatsuji","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1002\/hep.30054","article-title":"Hepatitis B Virus Evasion From Cyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase Sensing in Human Hepatocytes","volume":"68","author":"Verrier","year":"2018","journal-title":"Hepatology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e00725-17","DOI":"10.1128\/AAC.00725-17","article-title":"Persistent Loss of Hepatitis B Virus Markers in Serum without Cellular Immunity by Combination of Peginterferon and Entecavir Therapy in Humanized Mice","volume":"61","author":"Uchida","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e00183-17","DOI":"10.1128\/AAC.00183-17","article-title":"Development of a Novel Site-Specific Pegylated Interferon Beta for Antiviral Therapy of Chronic Hepatitis B Virus","volume":"61","author":"Tsuge","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s42826-019-0032-y","article-title":"Characterization and applications of chimeric mice with humanized livers for preclinical drug development","volume":"36","author":"Tateno","year":"2020","journal-title":"Lab. Anim. Res."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Nakagawa, S., Hirata, Y., Kameyama, T., Tokunaga, Y., Nishito, Y., Hirabayashi, K., Yano, J., Ochiya, T., Tateno, C., and Tanaka, Y. (2013). Targeted induction of interferon-lambda in humanized chimeric mouse liver abrogates hepatotropic virus infection. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0059611"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.antiviral.2017.11.008","article-title":"Efficacy of hepatitis B virus ribonuclease H inhibitors, a new class of replication antagonists, in FRG human liver chimeric mice","volume":"149","author":"Long","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/hep.24758","article-title":"Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation","volume":"55","author":"Lutgehetmann","year":"2012","journal-title":"Hepatology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1038\/s41467-019-10200-5","article-title":"Ciclopirox inhibits Hepatitis B Virus secretion by blocking capsid assembly","volume":"10","author":"Kang","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/hep.31712","article-title":"Dual Agonist of Farnesoid X Receptor and G Protein-coupled Receptor TGR5 Inhibits Hepatitis B Virus Infection in Vitro and in Vivo","volume":"74","author":"Ito","year":"2021","journal-title":"Hepatology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1038\/s41598-017-03946-9","article-title":"Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV\/HDV infected humanized mice","volume":"7","author":"Giersch","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jhep.2015.10.014","article-title":"Novel pH-sensitive multifunctional envelope-type nanodevice for siRNA-based treatments for chronic HBV infection","volume":"64","author":"Yamamoto","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jinf.2015.09.038","article-title":"Effect of tenofovir disoproxil fumarate on drug-resistant HBV clones","volume":"72","author":"Murakami","year":"2016","journal-title":"J. Infect."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"715450","DOI":"10.3389\/fmicb.2021.715450","article-title":"Animal Models for the Study of Hepatitis B Virus Pathobiology and Immunity: Past, Present, and Future","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1136\/gutjnl-2018-316091","article-title":"HBV infection-induced liver cirrhosis development in dual-humanised mice with human bone mesenchymal stem cell transplantation","volume":"68","author":"Yuan","year":"2019","journal-title":"Gut"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jhep.2016.04.022","article-title":"Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells","volume":"65","author":"Billerbeck","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Strick-Marchand, H., Dusseaux, M., Darche, S., Huntington, N.D., Legrand, N., Masse-Ranson, G., Corcuff, E., Ahodantin, J., Weijer, K., and Spits, H. (2015). A novel mouse model for stable engraftment of a human immune system and human hepatocytes. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0119820"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Bility, M.T., Cheng, L., Zhang, Z., Luan, Y., Li, F., Chi, L., Zhang, L., Tu, Z., Gao, Y., and Fu, Y. (2014). Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: Induction of human-specific liver fibrosis and M2-like macrophages. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004032"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/jnci\/djn243","article-title":"Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma","volume":"100","author":"Yang","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jcv.2007.03.005","article-title":"Hepatitis B virus (HBV) genotypes\/subgenotypes in China: Mutations in core promoter and precore\/core and their clinical implications","volume":"39","author":"Yuan","year":"2007","journal-title":"J. Clin. Virol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/hep.27722","article-title":"Characterization of the genotype and integration patterns of hepatitis B virus in early- and late-onset hepatocellular carcinoma","volume":"61","author":"Yan","year":"2015","journal-title":"Hepatology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0016-5085(00)70261-7","article-title":"Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B","volume":"118","author":"Kao","year":"2000","journal-title":"Gastroenterology"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1002\/hep.22929","article-title":"Clinical outcomes in adults with chronic hepatitis B in association with patient and viral characteristics: A systematic review of evidence","volume":"49","author":"Taylor","year":"2009","journal-title":"Hepatology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s00535-019-01558-w","article-title":"Comparison of intracellular responses between HBV genotype A and C infection in human hepatocyte chimeric mice","volume":"54","author":"Tsushima","year":"2019","journal-title":"J. Gastroenterol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2613.2001.iep178.x","article-title":"Hepatitis B virus and hepatocellular carcinoma","volume":"82","author":"Arbuthnot","year":"2001","journal-title":"Int. J. Exp. Pathol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1440-1746.2010.06592.x","article-title":"Reactive oxygen and mechanisms of inflammatory liver injury: Present concepts","volume":"26","author":"Jaeschke","year":"2011","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.jhep.2016.02.021","article-title":"Mechanisms of HBV-induced hepatocellular carcinoma","volume":"64","author":"Levrero","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1084\/jem.20110367","article-title":"Mitochondrial reactive oxygen species drive proinflammatory cytokine production","volume":"208","author":"Naik","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/j.gastro.2008.10.048","article-title":"Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes","volume":"136","author":"Sugiyama","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/hep.21345","article-title":"Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens","volume":"44","author":"Sugiyama","year":"2006","journal-title":"Hepatology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1126\/science.316.5825.682","article-title":"Biomedicine. Thymosins: Clinical promise after a decades-long search","volume":"316","author":"Marx","year":"2007","journal-title":"Science"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/07357907.2012.756111","article-title":"Roles and mechanisms of beta-thymosins in cell migration and cancer metastasis: An update","volume":"31","author":"Sribenja","year":"2013","journal-title":"Cancer Invest."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1158\/1541-7786.MCR-17-0715","article-title":"Tumor Progression Is Mediated by Thymosin-beta4 through a TGFbeta\/MRTF Signaling Axis","volume":"16","author":"Morita","year":"2018","journal-title":"Mol. Cancer Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1096\/fj.10-169417","article-title":"Regenerative protein thymosin beta-4 is a novel regulator of purinergic signaling","volume":"25","author":"Freeman","year":"2011","journal-title":"FASEB J."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4161\/cbt.13.4.18691","article-title":"Thymosin beta 4 in colorectal cancer is localized predominantly at the invasion front in tumor cells undergoing epithelial mesenchymal transition","volume":"13","author":"Nemolato","year":"2012","journal-title":"Cancer Biol. Ther."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.4081\/ejh.2014.2242","article-title":"Thymosin beta 4 and thymosin beta 10 expression in hepatocellular carcinoma","volume":"58","author":"Theunissen","year":"2014","journal-title":"Eur. J. Histochem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1006\/geno.1996.0645","article-title":"Localization of the L-glutamine synthetase gene to chromosome 1q23","volume":"38","author":"Clancy","year":"1996","journal-title":"Genomics"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cmet.2011.12.015","article-title":"The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type","volume":"15","author":"Yuneva","year":"2012","journal-title":"Cell Metab."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1002\/cncr.30851","article-title":"Genome-wide association analysis identifies a GLUL haplotype for familial hepatitis B virus-related hepatocellular carcinoma","volume":"123","author":"Lin","year":"2017","journal-title":"Cancer"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/hep.30111","article-title":"An Association Between Core Mutations in Hepatitis B Virus Genotype F1b and Hepatocellular Carcinoma in Alaskan Native People","volume":"69","author":"Hayashi","year":"2019","journal-title":"Hepatology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.virol.2018.08.020","article-title":"Endoplasmic reticulum-mediated induction of interleukin-8 occurs by hepatitis B virus infection and contributes to suppression of interferon responsiveness in human hepatocytes","volume":"525","author":"Tsuge","year":"2018","journal-title":"Virology"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/infdis\/jir247","article-title":"Effects of hepatitis B virus infection on the interferon response in immunodeficient human hepatocyte chimeric mice","volume":"204","author":"Tsuge","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_90","first-page":"489","article-title":"Electron microscopy and immunoelectronmicroscopy of cytoplasmic hepatitis B antigen in hepatocytes","volume":"75","author":"Gerber","year":"1974","journal-title":"Am. J. Pathol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1349-7006.2006.00235.x","article-title":"Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis","volume":"97","author":"Wang","year":"2006","journal-title":"Cancer Sci."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1128\/JVI.06442-11","article-title":"The hepatitis B virus X protein elevates cytosolic calcium signals by modulating mitochondrial calcium uptake","volume":"86","author":"Yang","year":"2012","journal-title":"J. Virol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.virusres.2006.09.011","article-title":"Hepatitis B virus X protein (HBx) activates ATF6 and IRE1-XBP1 pathways of unfolded protein response","volume":"124","author":"Li","year":"2007","journal-title":"Virus Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1042\/BJ20102071","article-title":"Endoplasmic reticulum stress induced by hepatitis B virus X protein enhances cyclo-oxygenase 2 expression via activating transcription factor 4","volume":"435","author":"Cho","year":"2011","journal-title":"Biochem. J."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"96027","DOI":"10.18632\/oncotarget.21630","article-title":"Hepatitis B virus X protein inhibits apoptosis by modulating endoplasmic reticulum stress response","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"31745","DOI":"10.1074\/jbc.M304202200","article-title":"Caspase-dependent alterations of Ca2+ signaling in the induction of apoptosis by hepatitis B virus X protein","volume":"278","author":"Chami","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Baudi, I., Isogawa, M., Moalli, F., Onishi, M., Kawashima, K., Ishida, Y., Tateno, C., Sato, Y., Harashima, H., and Ito, H. (2021). Interferon signaling suppresses the unfolded protein response and induces cell death in hepatocytes accumulating hepatitis B surface antigen. PLoS Pathog., 17.","DOI":"10.1371\/journal.ppat.1009228"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1084\/jem.20061287","article-title":"Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage","volume":"204","author":"Dunn","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.virol.2013.06.028","article-title":"Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha","volume":"444","author":"Pollicino","year":"2013","journal-title":"Virology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1128\/jvi.70.7.4558-4566.1996","article-title":"Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins","volume":"70","author":"Su","year":"1996","journal-title":"J. Virol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1053\/j.gastro.2015.05.058","article-title":"Interleukin-8 Induces Expression of FOXC1 to Promote Transactivation of CXCR1 and CCL2 in Hepatocellular Carcinoma Cell Lines and Formation of Metastases in Mice","volume":"149","author":"Huang","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_102","first-page":"5996","article-title":"Interleukin-8 serum levels in patients with hepatocellular carcinoma: Correlations with clinicopathological features and prognosis","volume":"9","author":"Ren","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"ref_103","first-page":"257","article-title":"Expression and function of interleukin-8 in human hepatocellular carcinoma","volume":"18","author":"Akiba","year":"2001","journal-title":"Int. J. Oncol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00432-003-0530-y","article-title":"Angiogenesis in hepatocellular carcinoma: The retrospectives and perspectives","volume":"130","author":"Sun","year":"2004","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1101\/gad.14.3.278","article-title":"Chk2\/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53","volume":"14","author":"Chehab","year":"2000","journal-title":"Gene Dev."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1101\/gad.14.3.289","article-title":"The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites","volume":"14","author":"Shieh","year":"2000","journal-title":"Genes Dev."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1535-6108(03)00110-7","article-title":"Chk1 and Chk2 kinases in checkpoint control and cancer","volume":"3","author":"Bartek","year":"2003","journal-title":"Cancer Cell"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/gutjnl-2016-313114","article-title":"CHK2 overexpression and mislocalisation within mitotic structures enhances chromosomal instability and hepatocellular carcinoma progression","volume":"67","author":"Carloni","year":"2018","journal-title":"Gut"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1158\/0008-5472.CAN-20-3134","article-title":"DNA Damage Response Protein CHK2 Regulates Metabolism in Liver Cancer","volume":"81","author":"Lulli","year":"2021","journal-title":"Cancer Res."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Song, S., Shi, Y., Wu, W., Wu, H., Chang, L., Peng, P., Zhang, L., Fan, J., Gu, J., and Ruan, Y. (2020). Reticulon 3-mediated Chk2\/p53 activation suppresses hepatocellular carcinogenesis and is blocked by hepatitis B virus. Gut.","DOI":"10.1136\/gutjnl-2020-321386"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1158\/0008-5472.CAN-14-1192","article-title":"Long noncoding RNA HULC modulates abnormal lipid metabolism in hepatoma cells through an miR-9-mediated RXRA signaling pathway","volume":"75","author":"Cui","year":"2015","journal-title":"Cancer Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.7150\/thno.34273","article-title":"LncRNA PCNAP1 modulates hepatitis B virus replication and enhances tumor growth of liver cancer","volume":"9","author":"Feng","year":"2019","journal-title":"Theranostics"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1038\/ncomms3218","article-title":"High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions","volume":"4","author":"Nault","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00535-015-1126-4","article-title":"Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features","volume":"51","author":"Asahina","year":"2016","journal-title":"J. Gastroenterol."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Ding, D., Lou, X.Y., Hua, D.S., Yu, W., Li, L.S., Wang, J., Gao, F., Zhao, N., Ren, G.P., and Li, L.J. (2012). Recurrent Targeted Genes of Hepatitis B Virus in the Liver Cancer Genomes Identified by a Next-Generation Sequencing-Based Approach. PLoS Genet., 8.","DOI":"10.1371\/journal.pgen.1003065"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ng.2295","article-title":"Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma","volume":"44","author":"Sung","year":"2012","journal-title":"Nat. Genet."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/286533a0","article-title":"Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma","volume":"286","author":"Brechot","year":"1980","journal-title":"Nature"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"8396","DOI":"10.1128\/JVI.00700-09","article-title":"Detection of clonally expanded hepatocytes in chimpanzees with chronic hepatitis B virus infection","volume":"83","author":"Mason","year":"2009","journal-title":"J. Virol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1101\/gr.133926.111","article-title":"The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients","volume":"22","author":"Jiang","year":"2012","journal-title":"Genome Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/ng.2291","article-title":"Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators","volume":"44","author":"Fujimoto","year":"2012","journal-title":"Nat. Genet."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"25075","DOI":"10.18632\/oncotarget.25308","article-title":"Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers","volume":"9","author":"Furuta","year":"2018","journal-title":"Oncotarget"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13148-020-00847-z","article-title":"The signature of HBV-related liver disease in peripheral blood mononuclear cell DNA methylation","volume":"12","author":"Li","year":"2020","journal-title":"Clin. Epigenet."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13073-016-0267-2","article-title":"Epigenetic impact of infection on carcinogenesis: Mechanisms and applications","volume":"8","author":"Hattori","year":"2016","journal-title":"Genome Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/hep.22110","article-title":"Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma","volume":"47","author":"Nishida","year":"2008","journal-title":"Hepatology"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jhep.2010.07.027","article-title":"Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake","volume":"54","author":"Lambert","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1053\/jhep.2000.19797","article-title":"Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis\u2014A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma","volume":"32","author":"Kondo","year":"2000","journal-title":"Hepatology"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.mrrev.2011.04.001","article-title":"Epigenetic mechanisms in hepatocellular carcinoma: How environmental factors influence the epigenome","volume":"727","author":"Herceg","year":"2011","journal-title":"Mutat. Res."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1053\/j.gastro.2013.10.056","article-title":"Hepatitis virus infection affects DNA methylation in mice with humanized livers","volume":"146","author":"Okamoto","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/ijc.28985","article-title":"Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma","volume":"136","author":"Chiba","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/hep.26083","article-title":"Histone lysine methyltransferase, suppressor of variegation 3-9 homolog 1, promotes hepatocellular carcinoma progression and is negatively regulated by microRNA-125b","volume":"57","author":"Fan","year":"2013","journal-title":"Hepatology"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/hep.30947","article-title":"HBx protein contributes to liver carcinogenesis by H3K4me3 modification through stabilizing WD repeat domain 5 protein","volume":"71","author":"Gao","year":"2020","journal-title":"Hepatology"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1038\/s41598-018-23318-1","article-title":"Delta-like 3 is silenced by HBx via histone acetylation in HBV-associated HCCs","volume":"8","author":"Hamamoto","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/1348-0421.12345","article-title":"Interaction of the hepatitis B virus X protein with the lysine methyltransferase SET and MYND domain-containing 3 induces activator protein 1 activation","volume":"60","author":"Hayashi","year":"2016","journal-title":"Microbiol. Immunol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/infdis\/jiaa317","article-title":"Signal Activation of Hepatitis B Virus-Related Hepatocarcinogenesis by Up-regulation of SUV39h1","volume":"222","author":"Takeuchi","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/ng1638","article-title":"A variable number of tandem repeats polymorphism in an E2F-1 binding element in the 5\u2019 flanking region of SMYD3 is a risk factor for human cancers","volume":"37","author":"Tsuge","year":"2005","journal-title":"Nat. Genet."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s12032-008-9144-1","article-title":"Hepatitis B virus X protein upregulates expression of SMYD3 and C-MYC in HepG2 cells","volume":"26","author":"Yang","year":"2009","journal-title":"Med. Oncol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.virusres.2008.09.006","article-title":"Hepatitis B virus-X protein recruits histone deacetylase 1 to repress insulin-like growth factor binding protein 3 transcription","volume":"139","author":"Shon","year":"2009","journal-title":"Virus Res."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/onc.2011.255","article-title":"Epigenetic repression of E-cadherin expression by hepatitis B virus x antigen in liver cancer","volume":"31","author":"Arzumanyan","year":"2012","journal-title":"Oncogene"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"42386","DOI":"10.1074\/jbc.M207418200","article-title":"Transcriptional activation of interleukin-8 by beta-catenin-Tcf4","volume":"277","author":"Levy","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1074\/jbc.M606774200","article-title":"The hepatitis B virus X protein functionally interacts with CREB-binding protein\/p300 in the regulation of CREB-mediated transcription","volume":"282","author":"Cougot","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/ncb1151","article-title":"SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells","volume":"6","author":"Hamamoto","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1002\/hep.30571","article-title":"The Antiresection Activity of the X Protein Encoded by Hepatitis Virus B","volume":"69","author":"Ren","year":"2019","journal-title":"Hepatology"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/10\/1920\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:04:29Z","timestamp":1760166269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/10\/1920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,24]]},"references-count":142,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["v13101920"],"URL":"https:\/\/doi.org\/10.3390\/v13101920","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,24]]}}}